Download PDFPDF

330 Firstline maintenance parp inhibitors in advanced ovarian cancer: a network meta-analysis for comparative efficacy and adverse events
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address